9 results on '"Yagi, Junji"'
Search Results
2. Adaptive Construction of the Immune Circuit
- Author
-
Tada, Tomio, primary, Asano, Yoshihiro, additional, Fujisawa, Isao, additional, Yagi, Junji, additional, Sano, Kunio, additional, Tsuji, Moriya, additional, and Nakayama, Toshinori, additional
- Published
- 1986
- Full Text
- View/download PDF
3. ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution
- Author
-
Castelli, Luca, Comi, Cristoforo, Chiocchetti, Annalisa, Nicola, Stefania, Mesturini, Riccardo, Giordano, Mara, D´Alfonso, Sandra, Cerutti, Elisa, Galimberti, Daniela, Fenoglio, Chiara, Tesser, Fabiana, Yagi, Junji, Rojo, José María, Perla, Franco, Leone, Maurizio, Scarpini, Elio, Monaco, Francesco, Dianzani, Umberto, Castelli, Luca, Comi, Cristoforo, Chiocchetti, Annalisa, Nicola, Stefania, Mesturini, Riccardo, Giordano, Mara, D´Alfonso, Sandra, Cerutti, Elisa, Galimberti, Daniela, Fenoglio, Chiara, Tesser, Fabiana, Yagi, Junji, Rojo, José María, Perla, Franco, Leone, Maurizio, Scarpini, Elio, Monaco, Francesco, and Dianzani, Umberto
- Abstract
Human ICOS is a T cell costimulatory molecule supporting IL10 secretion. A pilot study investigating variations of the ICOS gene 3'UTR detected 8 polymorphisms forming three haplotypes (A, B, C). Haplotype-A and -C displayed the highest difference. Activated T cells from healthy AA homozygotes expressed significantly less ICOS and secreted more IL10 than AC heterozygotes, whereas AB heterozygotes displayed intermediate levels. Analysis of 441 multiple sclerosis patients and 793 controls showed that frequency of AA homozygosity was significantly lower in MS patients with relapsing–remitting onset (N = 416) than in controls (OR = 0.70). Moreover, AA patients with relapsing–remitting onset had lower relapse rate and multiple sclerosis severity score than non-AA patients
- Published
- 2007
4. Immunotherapy of experimental melanoma with ICOS-Fc loaded in biocompatible and biodegradable nanoparticles
- Author
-
Roberta Cavalli, Filippo Renò, Monica Argenziano, Chiara Dianzani, Giuseppe Cappellano, Maria Josè Rojo, Benedetta Ferrara, Nausicaa Clemente, Francesco Trotta, Fabrizio Caldera, Annalisa Chiocchetti, Gianluca Miglio, Umberto Dianzani, Elena Boggio, Davide Raineri, Junji Yagi, Maria Teresa Capucchio, Luca Gigliotti, Associazione Italiana per la Ricerca sul Cancro, Fondazione ONLUS Amici di Jean, Fondazione Cariplo, Clemente, Nausicaa [0000-0002-9860-0148], Boggio, Elena [0000-0003-2700-3597], Gigliotti, Luca Casimiro [0000-0002-3127-5686], Raineri, Davide [0000-0003-3327-6305], Ferrara, Benedetta [0000-0002-2569-5115], Miglio, Gianluca [0000-0002-6602-2099], Argenziano, Monica [h0000-0002-8485-7460], Chiocchetti, Annalisa [0000-0002-4349-1087], Cappellano, Giuseppe [0000-0001-5193-4688], Caldera, Fabrizio [0000-0003-2581-0555], Capucchio, Maria Teresa [0000-0002-1068-0551], Yagi, Junji [0000-0002-0254-4760], Rojo, José María [0000-0001-9032-0072], Renò, Filippo [0000-0003-2410-4966], Cavalli, Roberta [0000-0002-2600-0661], Dianzani, Chiara [0000-0002-2246-3183], Dianzani, Umberto [0000-0001-6723-3931], Clemente, Nausicaa, Boggio, Elena, Gigliotti, Luca Casimiro, Raineri, Davide, Ferrara, Benedetta, Miglio, Gianluca, Argenziano, Monica, Chiocchetti, Annalisa, Cappellano, Giuseppe, Caldera, Fabrizio, Capucchio, Maria Teresa, Yagi, Junji, Rojo, José María, Renò, Filippo, Cavalli, Roberta, Dianzani, Chiara, and Dianzani, Umberto
- Subjects
medicine.medical_treatment ,Melanoma, Experimental ,Pharmaceutical Science ,Controlled release ,ICOS-L ,Melanoma ,PLGA nanoparticles ,β-Cyclodextrin nanosponges ,02 engineering and technology ,Inducible T-Cell Co-Stimulator Protein ,Inducible T-Cell Co-Stimulator Ligand ,Mice ,03 medical and health sciences ,chemistry.chemical_compound ,In vivo ,Combination cancer therapy ,Tumor Microenvironment ,medicine ,Animals ,030304 developmental biology ,Immunity, Cellular ,0303 health sciences ,Tumor microenvironment ,Chemistry ,FOXP3 ,Immunotherapy ,021001 nanoscience & nanotechnology ,medicine.disease ,Acquired immune system ,PLGA ,Cancer research ,Nanoparticles ,0210 nano-technology - Abstract
13 p.-7 fig.-1 tab., Inducible T-cell costimulator (ICOS) upon binding to its ligand (ICOSL) mediates adaptive immunity and antitumor response. Thus, antitumor therapies targeting the ICOS/ICOSL pathway hold great promise for cancer treatment. In this regard, ICOSL triggering by a soluble recombinant form of ICOS (ICOS-Fc) hampered adhesiveness and migration of dendritic, endothelial, and tumor cells in vitro. Furthermore, in vivo treatment with ICOS-Fc previously showed the capability to inhibit lung metastatization of ICOSL+ B16-F10 melanoma cells when injected intravenously in mice, but it failed to block the growth of established subcutaneous B16-F10 murine tumors. Thus, we asked whether passive targeting of solid tumors with ICOS-Fc-loaded biocompatible and biodegradable nanoparticles (NPs) could instead prove effectiveness in reducing tumor growth. Here, ICOS-Fc was loaded in two types of polymer nanoparticles, i.e. cross-linked β-cyclodextrin nanosponges (CDNS) and poly(lactic-co-glycolic acid) (PLGA) NPs and in vitro characterized. In vivo experiments showed that treatment of C57BL6/J mice with ICOS-Fc loaded into the two nanoformulations inhibits the growth of established subcutaneous B16-F10 tumors. This anticancer activity appears to involve both anti-angiogenic and immunoregulatory effects, as shown by decreased tumor vascularization and downmodulation of IL-10 and Foxp3, two markers of regulatory T cells (Tregs). Overall, the substantial in vivo anticancer activity of ICOS-Fc-loaded CDNS and PLGA NPs against different components of the tumor microenvironment makes these nanoformulations attractive candidates for future combination cancer therapy., This work was supported by the Associazione Italiana Ricerca sul Cancro (IG 20714, AIRC, Milano), Fondazione Amici di Jean (Torino), and Fondazione Cariplo (2017–0535).
- Published
- 2020
5. An accumulation of two populations of dendritic cells in skin-draining lymph nodes in response to the expression of thymic stromal lymphopoietin in the skin.
- Author
-
Omori-Miyake M, Watarai H, Sato K, Ziegler SF, and Yagi J
- Subjects
- Animals, Antigens, CD immunology, Antigens, CD metabolism, Cytokines physiology, Dendritic Cells physiology, Female, Integrin alpha Chains immunology, Integrin alpha Chains metabolism, Interleukin-17 metabolism, Lymph Nodes metabolism, Male, Mice, Mice, Inbred BALB C, Mice, Transgenic, Skin metabolism, T-Lymphocytes, Helper-Inducer metabolism, Th2 Cells metabolism, Thymic Stromal Lymphopoietin, Cytokines metabolism, Dendritic Cells metabolism
- Abstract
Thymic stromal lymphopoietin (TSLP) acts on dendritic cells (DCs), which prime helper T (Th) cells to become type 2 cytokine producing cells. Recently, a different set of populations of TSLP-responsive DCs has been discovered. Here, we identified two populations of CD103
lo EpCAMhi migratory DCs (fraction I and fraction II) that accumulated in skin-draining lymph nodes in response to TSLP expressed in the mouse skin. Fraction I DCs with CD11b+ PDL2hi expression primed naïve Th cells to differentiate into cells secreting IFN-γ, IL-17A and IL-22, while fraction II DCs with CD11blo PDL2+ expression primed naïve Th cells to differentiate into cells secreting IL-4, IL-5, IL-9, IL-13 and IL-10. Fraction I DCs migrated from the skin via IL-4Rα signaling pathway, whereas fraction II DCs migrated partially via TSLPR signaling pathway. All suggest that at least two populations of CD103lo EpCAMhi DCs with distinct functions and pathways could migrate in response to TSLP expression in the skin., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020 Elsevier Inc. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
6. In vitro assessment of IL-4- or IL-13-mediated changes in the structural components of keratinocytes in mice and humans.
- Author
-
Omori-Miyake M, Yamashita M, Tsunemi Y, Kawashima M, and Yagi J
- Subjects
- Animals, Cell Line, Dermatitis, Atopic genetics, Dermatitis, Atopic metabolism, Dermatitis, Atopic pathology, Desmocollins genetics, Desmocollins metabolism, Desmoglein 1 genetics, Desmoglein 1 metabolism, Epidermal Cells, Epidermis physiology, Humans, Keratin-1 genetics, Keratin-1 metabolism, Keratin-10 genetics, Keratin-10 metabolism, Keratinocytes cytology, Keratins, Hair-Specific genetics, Keratins, Hair-Specific metabolism, MAP Kinase Signaling System physiology, Membrane Glycoproteins genetics, Membrane Glycoproteins metabolism, Mice, Mice, Inbred BALB C, Mice, Knockout, Primary Cell Culture, Th2 Cells cytology, Interleukin-13 metabolism, Interleukin-3 metabolism, Interleukin-4 metabolism, Keratinocytes physiology, Th2 Cells physiology
- Abstract
T helper type 2 (Th2) cytokines, IL-4 and IL-13, attenuate the expression of genes that regulate epidermal cellular structures and the barrier function at the terminal stage of keratinocyte differentiation. However, whether these Th2 cytokines act at earlier stages remains unknown. We investigated the roles of cytokines in expression levels of mRNAs and/or proteins in primary mouse keratinocytes and human keratinocyte HaCaT cells at earlier stages. We showed that IL-4 downregulated the expression levels of Krt1, Krt10, Dsg1, and Dsc1 via IL-4Rα- and signal transducer and activator of transcription factor 6 (STAT6)-dependent mechanisms in differentiating mouse keratinocytes at early stages. As the expression levels of keratin-1 and -10 in the keratinocytes transiently expressing an active form of STAT6 were not downregulated, STAT6 and other IL-4-induced molecules may synergistically regulate this expression. The restoration of the downregulated expression levels of Krt1 and Krt10 induced by IL-4 with the MEK (mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase kinase) inhibitor U0126 indicated the involvement of the p44/42 MAPK signaling pathway in the attenuated expression. IL-13 also downregulated the expression of the four genes. Furthermore, IL-4 or IL-13 caused the downregulation of these genes in HaCaT cells and promoted the fragmentation of cell sheets with mechanical stress. Our results showed that IL-4 or IL-13 acted on differentiating keratinocytes in vitro at early stages to attenuate the gene expression.
- Published
- 2014
- Full Text
- View/download PDF
7. Possible involvement of T cell co-stimulation in pustulosis palmaris et plantaris via the induction of inducible co-stimulator in chronic focal infections.
- Author
-
Sakiyama H, Kobayashi S, Dianzani U, Ogiuchi H, Kawashima M, Uchiyama T, and Yagi J
- Subjects
- Adult, Aged, Antigens, CD metabolism, Antigens, Differentiation, T-Lymphocyte metabolism, B7-H1 Antigen, Biomarkers metabolism, CD4-Positive T-Lymphocytes metabolism, Chronic Disease, Female, Humans, Inducible T-Cell Co-Stimulator Protein, Male, Middle Aged, Periodontal Diseases immunology, Periodontal Diseases metabolism, Periodontal Diseases pathology, Psoriasis metabolism, Skin Diseases, Bacterial immunology, Skin Diseases, Bacterial metabolism, Skin Diseases, Bacterial pathology, Tonsillitis metabolism, CD4-Positive T-Lymphocytes immunology, CD4-Positive T-Lymphocytes pathology, Psoriasis immunology, Psoriasis pathology, Tonsillitis immunology, Tonsillitis pathology
- Abstract
Background: Inducible co-stimulator (ICOS) is a co-stimulatory receptor on activated T cells that provides the signals needed for Th1 and Th2 responses via its interaction with B7h. Chronic focal infections are closely related to pustulosis palmaris et plantaris (PPP), but the involvement of ICOS in PPP has not been clarified., Objective: To investigate the effectiveness of treatments for focal infections on PPP skin lesions and the involvement of ICOS-positive T cells at focal infection sites in the tonsils and in PPP lesional skin., Methods: In patients that had undergone a tonsillectomy or dental treatment, the clinical activities of PPP, both the skin lesions and pustulotic arthro-osteitis were followed for over 2 years. The expressions of ICOS and various other activation markers on T cells were examined in tonsil tissue from both PPP patients and non-PPP patients, and the expression levels in peripheral blood were also evaluated in PPP patients and healthy donors. ICOS-positive T cells and B7h expression in PPP and normal skin were examined immunohistochemically., Results: The above treatments for focal infections led to a dramatic and persistent improvement in the PPP skin lesions and pustulotic arthro-osteitis. The expression of ICOS, but not of other activation markers, was higher in tonsil tissues from PPP patients than in tonsil tissues from non-PPP patients. B7h was upregulated without numerous ICOS-positive T cell infiltrates in the skin lesions., Conclusion: The activation of T cells via ICOS co-stimulation in focal infections likely triggers the skin and skeletal inflammation associated with PPP, resulting in tissue damage.
- Published
- 2008
- Full Text
- View/download PDF
8. Long-term exposure to superantigen induces p27Kip1 and Bcl-2 expression in effector memory CD4+ T cells.
- Author
-
Koyanagi M, Fukada K, Uchiyama T, Yagi J, and Arimura Y
- Subjects
- Animals, CD4-Positive T-Lymphocytes cytology, CD4-Positive T-Lymphocytes metabolism, Cell Proliferation, Enterotoxins administration & dosage, Enterotoxins immunology, Female, Male, Mice, Mice, Inbred C57BL, T-Lymphocyte Subsets cytology, T-Lymphocyte Subsets immunology, T-Lymphocyte Subsets metabolism, CD4-Positive T-Lymphocytes immunology, Cyclin-Dependent Kinase Inhibitor p27 biosynthesis, Cyclin-Dependent Kinase Inhibitor p27 genetics, Immunologic Memory, Proto-Oncogene Proteins c-bcl-2 biosynthesis, Proto-Oncogene Proteins c-bcl-2 genetics, Superantigens immunology
- Abstract
The long-term exposure of mice to superantigen SEA using a mini-osmotic pump (SEA pump) induced a long-lasting expansion of Vbeta3+ CD4+ T cells with T helper (Th) 2 cell-type properties. Removal of the SEA pump 10 days after pump implantation did not significantly alter the level of Vbeta3+ CD4+ T cell expansion/maintenance. Furthermore, CFSE-labeled CD4+ T cells failed to divide when transferred to post-implantation day 15 mice. Thus, CD4+ T cells appeared to survive for at least 30 days in the absence of a sufficient amount of antigen to trigger cell division. STAT6 deficient mice, in which Th2 cell development is largely impaired, also exhibited a protracted cell expansion, similar to that observed in normal mice, suggesting that the Th2 cell property is dispensable for the maintenance of Vbeta3+ CD4+ T cell expansion. The expanded CD4+ T cells on post-implantation day 26 were arrested in the G0/G1 phase of the cell cycle and showed a lower level of cell division upon restimulation. The Cdk inhibitor p27(Kip1) was highly expressed, and Cdk2 was downregulated. Moreover, the CD4+ T cells were resistant to in vitro apoptosis induction in parallel with their level of Bcl-2 expression. Collectively, the Vbeta3+ CD4+ T cells appeared to develop into long-lived memory T cells with cell cycle arrest upon long-term exposure to SEA.
- Published
- 2007
- Full Text
- View/download PDF
9. CD28 is required for induction and maintenance of immunological memory in toxin-reactive CD4+ T cells in vivo.
- Author
-
Fukada K, Koyanagi M, Arimura Y, Ogiuchi H, Uchiyama T, and Yagi J
- Subjects
- Animals, CD28 Antigens genetics, CD4-Positive T-Lymphocytes cytology, CD4-Positive T-Lymphocytes metabolism, CD8-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes metabolism, Cell Proliferation, Cells, Cultured, Interferon-gamma biosynthesis, Interleukin-4 biosynthesis, Mice, Mice, Inbred C57BL, Mice, Knockout, Receptors, Antigen, T-Cell, alpha-beta metabolism, Up-Regulation, CD28 Antigens immunology, CD28 Antigens metabolism, CD4-Positive T-Lymphocytes drug effects, CD4-Positive T-Lymphocytes immunology, Enterotoxins pharmacology, Immunologic Memory drug effects, Immunologic Memory immunology
- Abstract
We previously reported that Vbeta3+ CD4+ T cells maintained a protracted expansion, with the phenotypes of memory Th2 cells, for 30 days in C57BL/6 (B6) mice implanted with SEA-containing mini-osmotic pumps. In the present study, we followed the fate of Vbeta3+ CD4+ T cells in CD28-/- mice. Vbeta3+ CD4+ T cells increased to a degree similar to that of B6 Vbeta3+ CD4+ T cells until day 10 after implantation, then declined rapidly reaching the control level by 28 days. Remaining Vbeta3+ CD4+ T cells at that time did not exhibit memory phenotypes nor Th2-deviated responses. The rapid drop in Vbeta3+ CD4+ T cells in CD28-/- mice was attributable to upregulated induction of apoptosis owing to marginal inductions of Bcl-2 and Bcl-xL. Collectively, these data indicate CD28 to play critical roles in the generation and maintenance of SEA-reactive CD4+ T cells in vivo.
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.